CNA urges Premiers to act on nursing solutions for better care and stronger health systems
Charlottetown, Prince Edward Island--(Newsfile Corp. - July 21, 2026) - As Canada's premiers gather in Charlottetown for the Council of the Federation summer meeting, the Canadian Nurses Association (CNA) is urging them to act on proven solutions that can improve access to care, support the nursing workforce, and strengthen health systems for people across Canada. With demand rising and too many people waiting too long for care, premiers have an opportunity to act now. By updating polic
2026-07-21 6:00 AM EDT | Canadian Nurses Association | Association des infirmières et infirmiers du Canada
L'AIIC invite les premiers ministres à miser sur des solutions infirmières pour améliorer les soins et renforcer les systèmes de santé
Charlottetown, Île-du-Prince-Édouard--(Newsfile Corp. - 21 juillet 2026) - Alors que les premières ministres et premiers ministres du Canada se réunissent à Charlottetown à l'occasion de la réunion estivale du Conseil de la fédération, l'Association des infirmières et infirmiers du Canada (AIIC) les exhorte à mettre en œuvre des solutions éprouvées qui peuvent améliorer l'accès aux soins, soutenir la main-d'œuvre infir
2026-07-21 6:00 AM EDT | Canadian Nurses Association | Association des infirmières et infirmiers du Canada
Restart Life Sciences Details U.S. E-Commerce Launch, AI Platform, and Three-Phase Expansion Strategy for Holy Crap Foods
Vancouver, British Columbia--(Newsfile Corp. - July 21, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is providing a corporate update regarding its upcoming expansion into the United States, the launch of an updated AI-driven e-commerce platform, and pipeline developments for its wholly owned subsidiary, Holy Crap Foods Inc. ("Holy Crap"). The Company remains focused on scaling operations, driving revenue generation, and
Technologies, Biotechnologies, Santé
2026-07-21 6:00 AM EDT | Restart Life Sciences Corp.
Tersis Technologies Appoints Vaughan B. Adnams as Chief Investment & Capital Markets Officer
Brooksville, Florida--(Newsfile Corp. - July 20, 2026) - Tersis Technologies, Inc. (OTCID: TERS) ("Tersis" or the "Company"), a clean technology company advancing next generation waste-to-energy and resource recovery solutions, today announced the appointment of Vaughan B. Adnams as Chief Investment & Capital Markets Officer, effective immediately.
Agriculture, Énergie, Énergies de substitution, Santé
2026-07-20 11:51 AM EDT | Tersis Technologies Inc.
QScreen AI Deepens US Institutional Pipeline as Screening Platform Adds Escalation-Based Review Capability
Toronto, Ontario--(Newsfile Corp. - July 20, 2026) - QScreen AI Inc. (CSE: QAI) (OTC: PMEDF) (FSE: 3QP) ("QScreen" or the "Company") today announced completion of the tiered screening architecture at the core of its commercialization strategy. The architecture is fully implemented in the Company's browser-based platform and is now being demonstrated to prospective institutional partners through the Company's US channel process, where a first signed evaluation agreement remains the stated
2026-07-20 7:01 AM EDT | QScreen AI Inc.
CBIH Unveils Cannabinoid-Based Intranasal Platform for Alzheimer's Research
Houston, Texas--(Newsfile Corp. - July 20, 2026) - Alzheimer's disease is not only a scientific challenge; it is a human crisis affecting millions of patients, families, caregivers, and healthcare systems. Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) is responding through an intranasal nanoemulsion platform designed to explore new possibilities in neurodegenerative care through cannabinoid-based and natural-compound science. CBIH's invention centers on an intranasal me
Biotechnologies, Pharmaceutique, Cannabis, Santé
2026-07-20 7:00 AM EDT | Cannabis Bioscience International Holdings
LevelJump Announces Revocation of Cease Trade Order; Seeking Reinstatement of Trading on TSX Venture Exchange
Toronto, Ontario--(Newsfile Corp. - July 17, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") is pleased to announce that, further to its news release of April 30, 2026, the Ontario Securities Commission has revoked a cease trade order that had been originally issued against the Company on May 6, 2026. The Company is now current on its continuous disclosure obligations under securities legislation. The Company is now in the process
Soins de santé et hôpitaux, Santé
2026-07-17 6:55 PM EDT | LevelJump Healthcare Corp.
Charlotte Janssen Announces Resignation as Independent Director of Metaguest.AI
Toronto, Ontario--(Newsfile Corp. - July 17, 2026) - Charlotte Janssen today announced her resignation as an independent director of Metaguest.AI Incorporated, a company listed on the Canadian Securities Exchange(the "Company"), effective immediately. After careful consideration, Ms. Janssen has concluded that it is no longer appropriate to continue serving on the Company's Board of Directors due to differing views regarding certain aspects of the Board's governance processes, de
Technologies, Construction / bâtiments, Santé, Juridique
2026-07-17 4:42 PM EDT | Charlotte Janssen
Edison Issues Report on Theon International (THEON)
London, United Kingdom--(Newsfile Corp. - July 17, 2026) - Edison issues report on Theon International (AMS: THEON). Theon International is a leading European developer and manufacturer of customisable night vision and thermal imaging systems for military and security applications with a global footprint spanning 72 countries. Having built a leading position in man-portable night vision, the company is now broadening into platform-based optronics and digital man-portable products, suppo
Services bancaires / financiers, Matériel informatique, Logiciels, Santé
2026-07-17 10:58 AM EDT | Edison Group
Red Light Holland Announces Corporate Rebrand to Rhelion Life Sciences Corp
Toronto, Ontario--(Newsfile Corp. - July 17, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") is pleased to announce that it will be changing its corporate name to Rhelion Life Sciences Corp ("Rhelion"), marking
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-07-17 7:50 AM EDT | Rhelion Life Sciences Corp.
Red Light Holland Announces New Filament Health PEX010 European Research Shipment
Toronto, Ontario--(Newsfile Corp. - July 16, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland", "Red Light", or the "Company") is an Ontario based organization advancing innovation and research within the legal psychedelic sector. Following its acquisition of Filament Health Corp. ("Filament"), the Company has expanded its pharmaceutical grade manufacturing, regulatory, and clinical research capabilities, supporting the advancement of naturally derived
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-07-16 8:03 AM EDT | Rhelion Life Sciences Corp.
Adia Med Inc. (Formerly Adia Nutrition Inc.) Launches Redesigned Corporate Website
Winter Park, Florida--(Newsfile Corp. - July 15, 2026) - Adia Med Inc. (OTCQB: ADIA), a clinical-stage regenerative medicine company, today announced the launch of its redesigned corporate website. The redesigned website is now live, with the project still in progress and active changes and improvements currently being made.
Soins de santé et hôpitaux, Santé
2026-07-15 9:30 AM EDT | Adia Med Inc.
WELL Health Closes $150 Million, 5-Year Senior Unsecured Notes Offering
Vancouver, British Columbia--(Newsfile Corp. - July 15, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, announces it has closed its previously announced inaugural private placement offering (the "Offering") of $150 million aggregate principal amount of 6.875% senior u
Technologies, Logiciels, Soins de santé et hôpitaux, Santé
2026-07-15 9:00 AM EDT | WELL Health Technologies Corp.
HarmonyRx Highlights 22 Years of Pharmacy Benefits Expertise, Building on Foundation as Broadreach Medical Research (BMR)
New York, New York--(Newsfile Corp. - July 15, 2026) - Since its founding as Broadreach Medical Research (BMR) in 2004, HarmonyRx has remained committed to transparency, clinical expertise and helping employers optimize pharmacy benefits. With more than two decades of experience in pharmacy benefits, HarmonyRx has grown alongside a rapidly changing healthcare landscape. As pharmacy costs have increased and benefit models have become more complex, the organization has remained focused on
2026-07-15 8:15 AM EDT | HarmonyRx
Extendicare Announces July 2026 Dividend of C$0.0441 per Share
Markham, Ontario--(Newsfile Corp. - July 15, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced that it has declared a cash dividend of C$0.0441 per common share of the Company for the month of July 2026, which is payable on August 17, 2026 to shareholders of record at the close of business on July 31, 2026. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare
Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-07-15 8:00 AM EDT | Extendicare Inc.
BioHarvest Awarded $1.4M Grant from the Israel Innovation Authority to Pioneer AI-Driven Plant-Cell Synthesis
British Columbia and Rehovot, Israel--(Newsfile Corp. - July 15, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that the Israel Innovation Authority (IIA) has approved a 4.33 million NIS (approximately USD $1.4 million) grant. This non-dilutive funding will support a new research initiative at BioHar
Biotechnologies, Pharmaceutique, Santé
2026-07-15 7:30 AM EDT | BioHarvest Sciences Inc.
Years of Preparation. One Regulatory Approval. Commercial Launch Begins: CBIH Receives Texas License for Consumable Hemp Products
Houston, Texas--(Newsfile Corp. - July 15, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today announced that the State of Texas has approved the Company's license to manufacture and distribute consumable hemp products. This approval turns years of vision, science, and preparation into action and marks the moment CBIH steps into the market and begins commercial distribution. The Company e
Biotechnologies, Pharmaceutique, Cannabis, Santé
2026-07-15 7:00 AM EDT | Cannabis Bioscience International Holdings
Phio Pharmaceuticals Announces Patent Milestone with Multiple Notices of Allowance and Grant Decision
King of Prussia, Pennsylvania--(Newsfile Corp. - July 15, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio Pharmaceuticals announced today significant progress in the protection of its proprietary innovations across key international markets. The company has received multiple favorable patent actions encompassing three
Biotechnologies, Soins de santé et hôpitaux, Pharmaceutique, Santé
2026-07-15 7:00 AM EDT | Phio Pharmaceuticals Corp.
LevelJump Announces 2026 Q1 Financial Results
Toronto, Ontario--(Newsfile Corp. - July 14, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce its financial results for the quarter ended March 31, 2026. Financial and Operational Highlights Revenues were $4.7 million in the first quarter of 2026 compared to $4.58 million in revenues for the first quarter of 2025, a year over year revenue increase of 2.7%. Canadian Teleradiology Se
Soins de santé et hôpitaux, Santé
2026-07-14 7:00 PM EDT | LevelJump Healthcare Corp.
LevelJump Announces 2025 Financial Results
Toronto, Ontario--(Newsfile Corp. - July 14, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce its financial results for the year ended December 31, 2025. Financial and Operational Highlights Revenues were $19.1 million in 2025 compared to $17.7 million in revenues for 2024, a year over year revenue increase of 7.9%. Canadian T
Soins de santé et hôpitaux, Santé
2026-07-14 6:30 PM EDT | LevelJump Healthcare Corp.